Zobrazeno 1 - 10
of 6 100
pro vyhledávání: '"Multidrug resistant TB (MDR-TB)"'
Autor:
Chowdhury K; Pediatrics, Gonoshasthaya Samaj Vittik Medical College, Dhaka, BGD., Ahmad R; Physiology, Medical College for Women and Hospital, Dhaka, BGD., Sinha S; Physiology, Khulna City Medical College, Khulna, BGD., Dutta S; Pharmacology, All India Institute of Medical Sciences, Rajkot, IND., Haque M; Pharmacology and Therapeutics, National Defence University of Malaysia, Kuala Lumpur, MYS.
Publikováno v:
Cureus [Cureus] 2023 Feb 18; Vol. 15 (2), pp. e35154. Date of Electronic Publication: 2023 Feb 18 (Print Publication: 2023).
Publikováno v:
Cureus.
Publikováno v:
Health Science Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
Abstract Background Tuberculosis (TB) remains a major public health concern in Pakistan, which is ranked fifth among high‐burden TB nations worldwide. The growing frequency of drug‐resistant TB strains, particularly multidrug‐resistant TB (MDR
Externí odkaz:
https://doaj.org/article/e8e76e29e6d347149f5bd4c0e3913a71
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70064 (2013)
BACKGROUND: The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-factorial and complex. Identifying patterns of treatment interruption that predict poor outcomes can be used to target program activities ai
Externí odkaz:
https://doaj.org/article/e77d4ec8f2ac451888833ce320243614
Autor:
Podewils, Laura Jean1, Gler, Maria Tarcela S.2, Quelapio, Maria Imelda2, Chen, Michael P.1 lpp8@cdc.gov
Publikováno v:
PLoS ONE. Jul2013, Vol. 8 Issue 7, p1-8. 8p.
Autor:
Mokaddas EM; Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.; Kuwait TB Control Unit, Shuwaikh, Kuwait., Ahmad S; Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait Suhail_ah@hsc.edu.kw., Eldeen HS; Kuwait TB Control Unit, Shuwaikh, Kuwait.
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2019 May 24; Vol. 57 (6). Date of Electronic Publication: 2019 May 24 (Print Publication: 2019).
With 10 million active disease cases, 558,000 cases of rifampin-resistant/multidrug-resistant tuberculosis (MDR-TB), and 1.6 million deaths recorded worldwide in 2017, TB is a leading cause of death from a single infectious agent ([1][1]). Early dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0d02adf0da854c1b9759c900e605a1
https://europepmc.org/articles/PMC6535618/
https://europepmc.org/articles/PMC6535618/
Autor:
Shafiq, Anam1 shafiqanam86@gmail.com, Khan, Haris Manzoor1, Shahid, Mohd.1, Fatima, Nazish1, Khan, Mo Ahamad
Publikováno v:
Journal of Pure & Applied Microbiology. Dec2024, Vol. 18 Issue 4, p2651-2658. 8p.
Autor:
Thampy, Parwathy1, Rupani, Ashlesh2, Chullithala, Athira3, Pawar, Neeraj4 neerajpawaraiimsrbl@gmail.com
Publikováno v:
Indian Journal of Psychiatry. Oct2024, Vol. 66 Issue 10, p875-886. 12p.
Chest X‐Ray Comparison Between Drug‐Resistant and Drug‐Sensitive Pulmonary Tuberculosis in Children.
Autor:
Zuhriyyah, Saffanah Az1 (AUTHOR), Nugraha, Harry Galuh2 (AUTHOR), Setiabudi, Djatnika3 (AUTHOR), Santoso, Prayudi4 (AUTHOR), Nataprawira, Heda Melinda3 (AUTHOR) heda.melinda@unpad.ac.id
Publikováno v:
Clinical Respiratory Journal. Sep2024, Vol. 18 Issue 9, p1-8. 8p.